Skip to main content
EJNMMI Physics
Fig. 9 | EJNMMI Physics

Fig. 9

From: Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates

Fig. 9

Intra-patient ratios between two treatment fractions vs. time between the fractions for a specific absorbed dose, b effective half-life and c specific uptake. ‘TATE first’: Ratios for a [177Lu]Lu-DOTATATE to a [177Lu]Lu-DOTATOC treatment, where [177Lu]Lu-DOTATATE was given before [177Lu]Lu-DOTATOC. ‘TOC first’: As ‘TATE first’, but with [177Lu]Lu-DOTATOC given first. ‘TATE consecutive’ and ‘TOC consecutive’: Ratios for consecutive treatments of either [177Lu]Lu-DOTATATE or [177Lu]Lu-DOTATOC. The dashed lines indicate a ratio of unity

Back to article page